NectinTX is a biotech company focused on unlocking the power of the immune system by developing a collection of next-gen immunotherapy agents.
Total raised: $36.4M
Investors 2
Date | Name | Website |
- | aMoon Fund | amoon.fund... |
- | Israel Bio... | ibf.fund |
Funding Rounds 3
Date | Series | Amount | Investors |
05.12.2022 | Series A | $25M | - |
09.03.2022 | - | $5.4M | - |
15.07.2020 | - | $6M | aMoon Fund |
Mentions in press and media 7
Date | Title | Description | Source |
31.12.2022 | Препарат израильской компания Nectin Therapeutics может прин... | 30 декабря 2022 г. Совершенно новый метод лечения не позволяет опухолевым клеткам «скрываться» и про... | vc.ru/s/13... |
30.11.2022 | Nectin Therapeutics Raises $25M for Immuno-Oncology Therapie... | What You Should Know: The company also announced dosing of the first patient in its Phase 1 clinica... | hitconsult... |
30.11.2022 | Nectin Therapeutics raises $25 million Series A to treat adv... | - | amoon.fund... |
09.03.2022 | Nectin Therapeutics Raises $5.4M in Funding | Nectin Therapeutics Ltd., a Jerusalem, Israel- and Fort lee, NJ-based based biotechnology company de... | finsmes.co... |
07.03.2022 | Nectin Therapeutics Announces $5.4 Million Investment from C... | - | amoon.fund... |
15.07.2020 | Israeli healthtech VC aMoon Velocity invests $6 million in N... | - | amoon.fund... |
- | Nectin Therapeutics | “NectinTX is a biotech company focused on unlocking the power of the immune system by developing a c... | fastfounde... |